Results of A Phase 1 Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma

被引：0
|
作者：
Christian, Beth [2 ]
Alinari, Lapo [1 ]
Jones, Jeffrey A. [2 ]
Benson, Don M., Jr. [2 ]
Flynn, Joseph M. [2 ]
Porcu, Pierluigi [2 ]
Lustberg, Mark E. [3 ]
Phelps, Mitchell [4 ]
Poi, Ming [4 ]
Chung, Diana [4 ]
Quinion, Carl [1 ]
Byrd, John C. [2 ]
Wegener, William [5 ]
Goldenberg, David M. [6 ]
Baiocchi, Robert A. [2 ]
Blum, Kristie A. [2 ]
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA
[3] Ohio State Univ, Div Infect Dis, Columbus, OH 43210 USA
[4] Ohio State Univ, Div Pharmaceut, Columbus, OH 43210 USA
[5] Immunomedics Inc, Morris Plains, NJ USA
[6] Ctr Mol Med & Immunol, Belleville, NJ USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1584 / 1584
页数：1
相关论文
共 50 条
  • [1] A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth
    Alinari, Lapo
    Earl, Christian Tyler
    Wilding, Emily
    Quinion, Carl
    Lustberg, Mark
    Benson, Don M., Jr.
    Jones, Jeffrey A.
    Byrd, John C.
    Wegener, William A.
    Goldenberg, David M.
    Baiocchi, Robert A.
    Blum, Kristie A.
    [J]. BLOOD, 2010, 116 (21) : 1148 - 1149
  • [2] The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma
    Christian, Beth A.
    Poi, Ming
    Jones, Jeffrey A.
    Porcu, Pierluigi
    Maddocks, Kami
    Flynn, Joseph M.
    Benson, Don M.
    Phelps, Mitch A.
    Wei, Lai
    Byrd, John C.
    Wegener, William A.
    Goldenberg, David M.
    Baiocchi, Robert A.
    Blum, Kristie A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (05) : 701 - 710
  • [3] Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results
    Morschhauser, Franck
    Leonard, John P.
    Fayad, Luis
    Coiffier, Bertrand
    Petillon, Marie-Odile
    Coleman, Morton
    Schuster, Stephen J.
    Dyer, Martin J. S.
    Horne, Heather
    Teoh, Nick
    Wegener, William A.
    Goldenberg, David M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) : 3346 - 3353
  • [4] VELTUZUMAB Humanized Anti-CD20 Monoclonal Antibody Oncolytic
    Bhat, S. A.
    Czuczman, M. S.
    [J]. DRUGS OF THE FUTURE, 2011, 36 (07) : 519 - 526
  • [5] Phase I study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody MIL62 in Chinese patients with relapsed/refractory CD20-positive B-cell non-Hodgkin's lymphoma
    Shi, Y-K.
    Song, Y.
    Qin, Y.
    Zhou, K.
    Gao, Y.
    Wang, M.
    Wang, P.
    Yin, Q.
    Zhao, F.
    Ma, G.
    Li, F.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S652 - S652
  • [6] Subcutaneous Veltuzumab, a Humanized Anti-CD20 Antibody, in the Treatment of Refractory Pemphigus Vulgaris
    Ellebrecht, Christoph T.
    Choi, Eun J.
    Allman, David M.
    Tsai, Donald E.
    Wegener, William A.
    Goldenberg, David M.
    Payne, Aimee S.
    [J]. JAMA DERMATOLOGY, 2014, 150 (12) : 1331 - 1335
  • [7] Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma
    Yuen, Sam
    Phillips, Tycel J.
    Bannerji, Rajat
    Marlton, Paula
    Gritti, Giuseppe
    Seymour, John F.
    Johnston, Anna
    Arthur, Christopher
    Dodero, Anna
    Sharma, Sunil
    Hirata, Jamie
    Musick, Lisa
    Flowers, Christopher R.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1281 - 1289
  • [8] Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphoma
    Negrea, George O.
    Elstrom, Rebecca
    Allen, Steven L.
    Rai, Kanti R.
    Abbasi, Rashid M.
    Farber, Charles M.
    Teoh, Nick
    Horne, Heather
    Wegener, William A.
    Goldenberg, David M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (04): : 567 - 573
  • [9] Functional Modulation of Dendritic Cells by Milatuzumab, a Humanized Anti-CD74 Monoclonal Antibody
    Chen, Xiaochuan
    Chang, Ken
    Goldenberg, David M.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 955 - 955
  • [10] Interest of a new humanized anti-CD20 antibody in relapsed or refractory LLC
    Cluzeau, Thomas
    [J]. HEMATOLOGIE, 2008, 14 (02): : 104 - 105
12345